Malegra 100 mg, which contains sildenafil (the same active ingredient as Viagra), is primarily used to treat erectile dysfunction (ED) and is metabolized by the liver, with a small portion excreted through the kidneys. In patients with kidney problems, sildenafil (Malegra 100 mg) should be approached with caution, as kidney function plays a role in how the drug is processed and eliminated from the body. Here's a breakdown of when Malegra 100 mg should be avoided or used with caution in patients with kidney issues: 1. Severe Kidney Impairment (CrCl < 30 mL/min) Avoid: Patients with severe renal impairment (i.e., creatinine clearance (CrCl) less than 30 mL/min) should avoid taking Malegra 100 mg or sildenafil. The drug may accumulate in the body because the kidneys are not able to clear it efficiently, increasing the risk of adverse effects like dizziness, headaches, and visual disturbances. Alternative: In cases of severe kidney disease, the doctor may opt for lower doses or alternative treatments for erectile dysfunction. 2. Mild to Moderate Kidney Impairment (CrCl 30–80 mL/min) Caution and Dose Adjustment: In patients with mild to moderate renal impairment, sildenafil can still be used, but dose adjustments may be required. The typical starting dose for individuals with kidney issues might be lower than the standard 100 mg (for example, 25 mg or 50 mg). The dose will depend on the severity of the kidney condition and the patient's response to the medication. Close monitoring is essential to minimize side effects.